Results 51 to 60 of about 23,719 (217)

Urticaria and angioedema

Allergy, Asthma & Clinical Immunology, 2011
Urticaria (hives) is a common disorder that often presents with angioedema (swelling that occurs beneath the skin). It is generally classified as acute, chronic or physical.
A. Kanani, R Robert Schellenberg, Richard Warrington   +2 more
semanticscholar   +1 more source

Analysis of Sleep Quality in Patients with Hereditary Angioedema

ABCS Health Sciences
Introduction: Sleep plays a crucial role in human health, both physiologically and mentally, responsible for body repair and regeneration. This may be affected by patients with Hereditary Angioedema (HAE), a rare and serious genetic disease of the ...
Tatielly Kruk, Lucas Marques Fortunato, Caroline Guth de Freitas Batista de Moraes, Charles Francisco Ferreira, Laura Baccule Brandão, João Guilherme Fiorani Borgio, Herberto José Chong-Neto, Lilian Pereira Ferrari, Nelson Augusto Rosário Filho   +8 more
doaj   +1 more source

Art v 1 and Amb a 4 Co‐Sensitization Identifies Italian Patients at Risk for Mugwort‐Celery‐Spice Syndrome

Allergy, EarlyView.
Three molecular profiles identified among Art v 1/Amb a 4‐sensitized patients: Art v 1 monosensitization, Amb a 4 monosensitization, and dual sensitization to both allergens. Art v 1 monosensitization was predominantly associated with allergic rhinitis, reflecting a classical airborne allergy pattern.
Enrico Scala, Gabriella Cusa, Valeria Villella, Damiano Abeni, Mauro Giani, Emma Cristina Guerra, Maria Locanto, Giorgia Meneguzzi, Lia Pirrotta, Donato Quaratino, Alessandra Zaffiro, Elisabetta Caprini, Maria Barrale, Ignazio Brusca, Valerio Pravettoni, Lorenzo Cecchi, Danilo Villalta, Martina Aumayr, Irene Mittermann, Christian Lupinek, Riccardo Asero   +20 more
wiley   +1 more source

Unmet needs in the management of hereditary angioedema from the perspective of Brazilian patients

World Allergy Organization Journal
Introduction: Hereditary angioedema (HAE) is a rare genetic disease characterized by recurrent, potentially life-threatening angioedema episodes. Despite its severity, including the risk of asphyxiation, HAE often remains underdiagnosed.
Pedro Giavina-Bianchi, MD, PhD, Mara Giavina-Bianchi, MD, PhD, Raquel de Oliveira Martins, Maria Cristina Fortunato, PharmD, Ana Claudia Guersoni, MD, PhD   +4 more
doaj   +1 more source

Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry

Allergy, EarlyView.
Appropriate treatment escalation improves CSU disease control. However, only about a quarter of patients achieve a complete response, the main goal of CSU treatment. Approximately one‐third of patients clinically eligible for escalation (UCT < 12) do not receive guideline‐recommended treatment escalation and remain symptomatic on their current ...
Pavel Kolkhir, Pascale Salameh, Magdalena Zajac, Alicja Kasperska‐Zajac, Ana Giménez‐Arnau, Maria Puertolas, Hanna Bonnekoh, Carolina Vera Ayala, Michael Makris, Eleni Chatzidimitriou, Stamatios Gregoriou, Kanokvalai Kulthanan, Andrea Bauer, Mojca Bizjak‐Suran, Daria Fomina, Alexis Bocquet, Joachim Dissemond, Mohamed Abuzakouk, Tara Raftery, Nadine Chapman‐Rothe, Emek Kocatürk, Clive Grattan, Riccardo Asero, Jonny G. Peter, Simon Francis Thomsen, Karsten Weller   +25 more
wiley   +1 more source

ID280 MHT para profilaxia de crises de AEH tipo I e II para maiores de 2 anos de idade, gestantes ou lactantes

Jornal de Assistência Farmacêutica e Farmacoeconomia
Introdução O angioedema hereditário (AEH) por deficiência de C1-esterase é uma doença genética rara caracterizada pela deficiência ou disfunção do inibidor do C1-INH, também denominada tipo I ou tipo II.
Aramís Tupiná Alcântara de Moreira, Thais Conceição Borges, Ana Carolina de Freitas Lopes, Luciene Fontes Schluckebier Bonan   +3 more
doaj   +1 more source

P60: INTRODUCTION OF BERINERT® SC (HUMAN C1‐ESTERASE INHIBITOR) ADMINISTRATION IN THE HOME SETTING TO SUPPORT PROPHYLACTIC TREATMENT OF HEREDITARY ANGIOEDEMA PATIENTS [PDF]

, 2021

openalex   +1 more source

Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy

Allergy, EarlyView.
BL‐Predictor has emerged as a new tool for delabeling penicillin allergy. External validation has shown a specificity of 93% for detecting low‐risk patients. This score could potentially reduce diagnostic costs and the negative consequences associated with incorrect antibiotic allergy labels.
Marina Labella, Rafael Nuñez, Inmaculada Doña, Julia Rodríguez de Guzmán, Esther Moreno, Lene Heise Garvey, Jose Julio Laguna, Annick Barbaud, Patrizia Bonnadona, Jonas Bredtoft Boel, Holger Mosbech, Giovanna Sfriso, Mariana Castells, Elizabeth Phillips, María José Torres   +14 more
wiley   +1 more source

Eritema, edema localizado y calor versus aumento del perímetro del antebrazo. ¿Ha llegado el momento de revisar las recomendaciones de consenso de la prueba de provocación del vórtice en urticaria-angioedema vibratorios?

Actas Dermo-Sifiliográficas
Resumen: Antecedentes y objetivo: En urticaria/angioedemas vibratorios se ha consensuado que la respuesta positiva al test de provocación del vórtice se defina en función del aumento del perímetro del antebrazo estandarizar la prueba del vórtice ...
M.E. Gatica-Ortega, B. Sánchez-Albisua, D.M. Arranz-Sánchez, B. Pérez-Tato, A. Sánchez-Gilo, S. Córdoba-Guijarro, F.J. Ortiz-Frutos, N. Hernández-Cano, E. Gómez de la Fuente, M. Elosua-González, M. Bergón-Sendín, C. García-Martín, T. Sanz-Sánchez, O. Mazuela-Díez, R. Torres-Aranda, L. Vergara-de-la-Campa, S. Marinero-Escobedo, A. Alegre-Bailo, A. Garrido-Ríos, F. Tous-Romero, J.M. Busto-Leis, C. Sarró-Fuente, F.J. Rodríguez-Cuadrado, P. García-Piqueras, P. Beneyto, M.A. Pastor-Nieto   +25 more
doaj   +1 more source

The Optimal Emergency Department Management of Out‐of‐Hospital Supraglottic Airways

Academic Emergency Medicine, EarlyView.
Aaron E. Robinson, Matthew E. Prekker, Marc L. Martel, Brian E. Driver   +3 more
wiley   +1 more source